錯誤 Q3 --12-31 2024-09-30 2024 0001786286 0001786286 2024-01-01 2024-09-30 0001786286 2024-09-30 0001786286 2023-12-31 0001786286 2024-07-01 2024-09-30 0001786286 2023-07-01 2023-09-30 0001786286 2023-01-01 2023-09-30 0001786286 ifrs-full:已發行股本成員 2022-12-31 0001786286 ifrs-full:股份支付儲備成員 2022-12-31 0001786286 ifrs-full:認股權證成員 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-12-31 0001786286 ifrs-full:翻譯儲備準備成員 2022-12-31 0001786286 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-09-30 0001786286 ifrs全準則:股本支付儲備成員 2023-09-30 0001786286 ifrs全準則:認股權成員 2023-09-30 0001786286 ifrs全準則:留存收益成員 2023-09-30 0001786286 ifrs全準則:投資權益工具收益和損失儲備成員 2023-09-30 0001786286 ifrs全準則:外匯轉換差額儲備成員 2023-09-30 0001786286 2023-09-30 0001786286 ifrs全準則:已發行資本成員 2023-12-31 0001786286 ifrs全準則:股本支付儲備成員 2023-12-31 0001786286 ifrs全準則:認股權成員 2023-12-31 0001786286 ifrs-full:留存收益成員 2023-12-31 0001786286 ifrs-full:權益工具投資收益和損失準儲 2023-12-31 0001786286 ifrs-full:外匯差額準儲 2023-12-31 0001786286 ifrs-full:已發行資本成員 2023-01-01 2023-09-30 0001786286 ifrs-full:股份支付準備金 2023-01-01 2023-09-30 0001786286 ifrs-full:認股權證成員 2023-01-01 2023-09-30 0001786286 ifrs-full:留存收益成員 2023-01-01 2023-09-30 0001786286 ifrs-full:權益工具投資收益和損失準儲 2023-01-01 2023-09-30 0001786286 ifrs全面:翻譯成員的匯兌差額儲備 2023-01-01 2023-09-30 0001786286 ifrs全面:已發行資本成員 2023-10-01 2023-12-31 0001786286 ifrs全面:基於股份支付成員的準備金 2023-10-01 2023-12-31 0001786286 ifrs全面:權證成員 2023-10-01 2023-12-31 0001786286 ifrs全面:留存收益成員 2023-10-01 2023-12-31 0001786286 ifrs全面:權益工具投資中的收益和損失準備金 2023-10-01 2023-12-31 0001786286 ifrs全面:翻譯成員的匯兌差額儲備 2023-10-01 2023-12-31 0001786286 2023-10-01 2023-12-31 0001786286 ifrs全面:已發行資本成員 2024-01-01 2024-09-30 0001786286 ifrs全文:股份支付儲備成員 2024-01-01 2024-09-30 0001786286 ifrs全文:權證成員 2024-01-01 2024-09-30 0001786286 ifrs全文:留存收益成員 2024-01-01 2024-09-30 0001786286 ifrs全文:股權工具投資收益和損失儲備成員 2024-01-01 2024-09-30 0001786286 ifrs全文:翻譯報表外匯差額儲備成員 2024-01-01 2024-09-30 0001786286 ifrs全文:已發行股本成員 2024-09-30 0001786286 ifrs全文:股份支付儲備成員 2024-09-30 0001786286 ifrs全文:權證成員 2024-09-30 0001786286 IFRS全量財務報表:留存收益成員 2024-09-30 0001786286 IFRS全量財務報表:權益工具投資中的收益和損失準備成員 2024-09-30 0001786286 IFRS全量財務報表:外匯差額調整準備成員 2024-09-30 0001786286 DPRO:Dragonfly Innovations Inc 成員 2024-01-01 2024-09-30 0001786286 DPRO:Draganfly Innovations USA Inc 成員 2024-01-01 2024-09-30 0001786286 DPRO:Dronelogics Systems Inc 成員 2024-01-01 2024-09-30 0001786286 DPRO:上市公司股票成員 2024-09-30 0001786286 DPRO:私人公司股票成員 2024-09-30 0001786286 DPRO:上市公司成員 2024-01-01 2024-09-30 0001786286 DPRO:私營公司成員 2024-01-01 2024-09-30 0001786286 DPRO:私營公司成員 2024-07-01 2024-09-30 0001786286 ifrs全文:計算機設備成員 2022-12-31 0001786286 DPRO:傢俱和設備成員 2022-12-31 0001786286 ifrs-full:租賃改進成員 2022-12-31 0001786286 車輛成員 2022-12-31 0001786286 ifrs-full:計算機設備成員 2023-01-01 2023-12-31 0001786286 DPRO:傢俱和設備成員 2023-01-01 2023-12-31 0001786286 ifrs-full:租賃改善成員 2023-01-01 2023-12-31 0001786286 ifrs-full:車輛成員 2023-01-01 2023-12-31 0001786286 2023-01-01 2023-12-31 0001786286 ifrs-full:計算機設備成員 2023-12-31 0001786286 DPRO:傢俱和設備成員 2023-12-31 0001786286 ifrs-full:租賃改善成員 2023-12-31 0001786286 ifrs-full:車輛成員 2023-12-31 0001786286 ifrs-full:計算機設備成員 2024-01-01 2024-09-30 0001786286 DPRO:傢俱和設備成員 2024-01-01 2024-09-30 0001786286 ifrs-full:租賃改良成員 2024-01-01 2024-09-30 0001786286 ifrs-full:車輛成員 2024-01-01 2024-09-30 0001786286 ifrs-full:電腦設備成員 2024-09-30 0001786286 DPRO:傢俱和設備成員 2024-09-30 0001786286 ifrs-full:租賃改良成員 2024-09-30 0001786286 ifrs-full:車輛成員 2024-09-30 0001786286 建築物 2022-12-31 0001786286 IFRS全文:土地會員 2022-12-31 0001786286 IFRS全文:建築成員 2023-01-01 2023-12-31 0001786286 IFRS全文:土地成員 2023-01-01 2023-12-31 0001786286 IFRS全文:建築成員 2023-12-31 0001786286 IFRS全文:土地成員 2023-12-31 0001786286 IFRS全文:建築成員 2024-01-01 2024-09-30 0001786286 IFRS全文:土地成員 2024-01-01 2024-09-30 0001786286 IFRS全文:建築成員 2024-09-30 0001786286 IFRS全面:土地會員 2024-09-30 0001786286 DPRO: 租賃一個設施會員 2024-01-01 2024-09-30 0001786286 DPRO: 租賃兩個設施會員 2024-01-01 2024-09-30 0001786286 DPRO: 租賃三個設施會員 2024-01-01 2024-09-30 0001786286 DPRO: 租賃四個設施會員 2024-01-01 2024-09-30 0001786286 ifrs-full:範圍底部成員 2024-09-30 0001786286 ifrs-full:範圍頂部成員 2024-09-30 0001786286 ifrs-full:不遲於一年會員 2024-09-30 0001786286 ifrs-full:一年後但不遲於三年成員 2024-09-30 0001786286 超過4年但不超過5年以後 2024-09-30 0001786286 DPRO:加拿大緊急企業帳戶會員 2024-09-30 0001786286 DPRO:加拿大緊急企業帳戶會員 2023-12-31 0001786286 DPRO:加拿大緊急企業帳戶會員 2024-01-01 2024-09-30 0001786286 DPRO:加拿大緊急企業帳戶貸款會員 2024-09-30 0001786286 DPRO:加拿大緊急企業帳戶貸款會員 2023-12-31 0001786286 DPRO:加拿大緊急企業帳戶貸款會員 2024-01-01 2024-09-30 0001786286 DPRO: 車輛貸款會員 2024-09-30 0001786286 DPRO: 車輛貸款會員 2023-12-31 0001786286 DPRO: 車輛貸款會員 2024-01-01 2024-09-30 0001786286 DPRO: 普通股票1會員 2024-01-01 2024-09-30 0001786286 DPRO: 美元指數預資劵會員 2024-02-26 0001786286 DPRO: 美元指數預資劵會員 2024-02-26 2024-02-26 0001786286 DPRO: 普通股份會員 DPRO: 美元指數預資劵會員 2024-02-26 2024-02-26 0001786286 ifrs-full:權證成員 DPRO : 美元預資助認股權成員 2024-02-26 2024-02-26 0001786286 DPRO : 美元預資助認股權成員 2024-03-27 0001786286 DPRO : 加元預資助認股權成員 2024-04-29 0001786286 DPRO : 加元預資助認股權成員 2024-04-29 2024-04-29 0001786286 DPRO : 普通股成員 DPRO : 加元預資助認股權成員 2024-04-29 2024-04-29 0001786286 ifrs-full:權證成員 DPRO: 加拿大預擔保認股權證會員 2024-04-29 2024-04-29 0001786286 DPRO: 加拿大預擔保認股權證會員 2024-08-21 0001786286 DPRO: 加拿大預擔保認股權證會員 2024-08-21 2024-08-21 0001786286 ifrs-full:認股權證會員 DPRO: 加拿大預擔保認股權證會員 2024-08-21 2024-08-21 0001786286 DPRO: 普通股票1會員 2023-01-01 2023-12-31 0001786286 DPRO: 普通股份會員 2023-01-01 2023-12-31 0001786286 DPRO: 普通股份會員 2023-12-31 0001786286 2024-09-05 0001786286 DPRO:股票期權會員 2024-07-01 2024-09-30 0001786286 DPRO:股票期權會員 2023-07-01 2023-09-30 0001786286 DPRO:股票期權會員 2024-01-01 2024-09-30 0001786286 DPRO:股票期權會員 2023-01-01 2023-09-30 0001786286 DPRO:受限股票單位會員 2024-07-01 2024-09-30 0001786286 DPRO:受限股票單位會員 2023-07-01 2023-09-30 0001786286 DPRO:受限股票單位會員 2024-01-01 2024-09-30 0001786286 DPRO:受限股票單位會員 2023-01-01 2023-09-30 0001786286 2024-08-07 2024-08-07 0001786286 DPRO:十月權證會員 2024-08-07 0001786286 DPRO:行使價第一會員 DPRO:激勵股份補償計劃會員 2024-01-01 2024-09-30 0001786286 DPRO:行使價第一會員 DPRO:激勵股份補償計劃會員 2024-09-30 0001786286 DPRO:行使價第二會員 DPRO:激勵股份補償計劃會員 2024-01-01 2024-09-30 0001786286 DPRO:行使價第二會員 DPRO:激勵股份補償計劃會員 2024-09-30 0001786286 DPRO:行權價三會員 DPRO:激勵股份補償計劃會員 2024-01-01 2024-09-30 0001786286 DPRO:行權價三會員 DPRO:激勵股份補償計劃會員 2024-09-30 0001786286 DPRO:行權價四會員 DPRO:激勵股份補償計劃會員 2024-01-01 2024-09-30 0001786286 DPRO:行權價四會員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:行權價爲五成員 DPRO:激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO:行權價爲五成員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:行權價爲六成員 DPRO:激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO:行權價爲六成員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:行權價格七名成員 DPRO:激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO:行權價格七名成員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:行權價格八名成員 DPRO:激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO:行權價格八名成員 DPRO: 激勵股份補償計劃成員 2024-09-30 0001786286 DPRO: 行權價九成員 DPRO: 激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO: 行權價九成員 DPRO: 激勵股份補償計劃成員 2024-09-30 0001786286 DPRO: 行權價十成員 DPRO: 激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO: 行權價十成員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:行權價格11位成員 DPRO:激勵股份補償計劃成員 2024-01-01 2024-09-30 0001786286 DPRO:行權價格11位成員 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:激勵股份補償計劃成員 2024-09-30 0001786286 DPRO:受限股票單位成員 2022-12-31 0001786286 DPRO:受限股票單位成員 2023-01-01 2023-12-31 0001786286 DPRO:限制性股票單位成員 2023-12-31 0001786286 DPRO:限制性股票單位成員 2024-09-30 0001786286 ifrs-full:認股權證成員 DPRO:二月發行成員 2024-01-01 2024-09-30 0001786286 DPRO:經紀人成員 DPRO:二月發行成員 2024-01-01 2024-09-30 0001786286 ifrs-full:認股權證成員 DPRO:四月發行成員 2024-01-01 2024-09-30 0001786286 DPRO:經紀會員 DPRO:四月發行會員 2024-01-01 2024-09-30 0001786286 DPRO:經紀會員 DPRO:八月發行會員 2024-01-01 2024-09-30 0001786286 ifrs-full:認股權證會員 2022-12-31 0001786286 ifrs-full:認股權證會員 2023-01-01 2023-12-31 0001786286 ifrs-full:認股權證會員 2023-12-31 0001786286 ifrs-full:認股權證會員 2024-01-01 2024-09-30 0001786286 ifrs-full:WarrantsMember 2024-09-30 0001786286 DPRO : Range 1 Member 2024-01-01 2024-09-30 0001786286 DPRO : Range 1 Member 2024-09-30 0001786286 DPRO : Range 1 Member 2023-12-31 0001786286 DPRO : Range 2 Member 2024-01-01 2024-09-30 0001786286 DPRO : Range 2 Member 2024-09-30 0001786286 DPRO : Range 2 Member 2023-12-31 0001786286 DPRO : Range 3 Member 2024-01-01 2024-09-30 0001786286 DPRO:範圍3成員 2024-09-30 0001786286 DPRO:範圍3成員 2023-12-31 0001786286 DPRO:範圍5成員 2024-09-30 0001786286 DPRO:範圍6成員 2024-09-30 0001786286 ifrs-full:認股權證成員 2024-01-01 2024-09-30 0001786286 ifrs-full:認股權證成員 2023-01-01 2023-12-31 0001786286 ifrs-full:認股權證成員 2022-12-31 0001786286 ifrs-full:認股權證成員 2023-12-31 0001786286 ifrs-full:認股權證成員 2024-09-30 0001786286 DPRO:認股權證一號成員 2024-01-01 2024-09-30 0001786286 DPRO:認股權證一號成員 2024-09-30 0001786286 DPRO:認股權證二號成員 2024-01-01 2024-09-30 0001786286 DPRO:認股權證二號成員 2024-09-30 0001786286 DPRO:認股權證三號成員 2024-01-01 2024-09-30 0001786286 DPRO:認股權證三號成員 2024-09-30 0001786286 DPRO:認股權證四號成員 2024-01-01 2024-09-30 0001786286 DPRO:權證四成員 2024-09-30 0001786286 DPRO:權證五成員 2024-01-01 2024-09-30 0001786286 DPRO:權證五成員 2024-09-30 0001786286 DPRO:權證六成員 2024-01-01 2024-09-30 0001786286 DPRO:權證六成員 2024-09-30 0001786286 DPRO:權證七成員 2024-01-01 2024-09-30 0001786286 DPRO:權證七成員 2024-09-30 0001786286 DPRO:權證八成員 2024-01-01 2024-09-30 0001786286 DPRO:八號成員 2024-09-30 0001786286 DPRO:無人機成員 2024-01-01 2024-09-30 0001786286 DPRO:重要成員 2024-01-01 2024-09-30 0001786286 DPRO:公司成員 2024-01-01 2024-09-30 0001786286 DPRO:無人機成員 2023-01-01 2023-09-30 0001786286 DPRO:重要成員 2023-01-01 2023-09-30 0001786286 DPRO:公司成員 2023-01-01 2023-09-30 0001786286 國家:加拿大 2024-09-30 0001786286 國家:加拿大 2023-12-31 0001786286 國家:美國 2024-09-30 0001786286 國家:美國 2023-12-31 0001786286 國家:加拿大 2024-07-01 2024-09-30 0001786286 國家:加拿大 2023-07-01 2023-09-30 0001786286 國家:加拿大 2024-01-01 2024-09-30 0001786286 國家:加拿大 2023-01-01 2023-09-30 0001786286 國家:美國 2024-07-01 2024-09-30 0001786286 國家:美元指數 2023-07-01 2023-09-30 0001786286 國家:美元指數 2024-01-01 2024-09-30 0001786286 國家:美元指數 2023-01-01 2023-09-30 0001786286 DPRO: 首席執行官和董事成員 2024-07-01 2024-09-30 0001786286 DPRO: 首席執行官和董事成員 2023-07-01 2023-09-30 0001786286 DPRO: 首席執行官和董事成員 2024-01-01 2024-09-30 0001786286 DPRO: 首席執行官和董事成員 2023-01-01 2023-09-30 0001786286 DPRO: 首席執行官成員 2024-07-01 2024-09-30 0001786286 DPRO:首席執行官會員 2023-07-01 2023-09-30 0001786286 DPRO:首席執行官會員 2024-01-01 2024-09-30 0001786286 DPRO:首席執行官會員 2023-01-01 2023-09-30 0001786286 DPRO:總裁兼董事會成員 2024-07-01 2024-09-30 0001786286 DPRO:總裁兼董事會成員 2023-07-01 2023-09-30 0001786286 DPRO:總裁兼董事會成員 2024-01-01 2024-09-30 0001786286 DPRO:總裁兼董事會成員 2023-01-01 2023-09-30 0001786286 ifrs-full: 其他相關方會員 2024-07-01 2024-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-07-01 2023-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-09-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-09-30 0001786286 公允價值層次結構一級成員 2024-09-30 0001786286 2023-12-31 2024-09-30 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001786286 0001813783 2024-01-01 2024-09-30 0001786286 ifrs-full:股份的歷史波動率測量輸入成員 2023-01-01 2023-12-31 iso4217:美元指數 xbrli:股份 iso4217:美元指數 xbrli:股份 xbrli:純形 ISO 4217:CAD xbrli:股份 iso4217:CAD

 

展覽 99.1

 

 

Draganfly 公司。

 

未經審計的總結之中期基本報表 - 未經審計

 

截至2024年9月30日的三個月和九個月

 

(以加拿大元表示)

 

 
 

 

Draganfly 公司。

濃縮 綜合中期財務狀況報表 - 未經審核

以加拿大元表示

 

      九月 30,   十二月 31日, 
截至 在  註釋  2024   2023 
            
資產             
流動資產             
現金     $3,997,577   $3,093,612 
應收帳款  4   854,169    649,612 
庫存  5   1,510,371    1,596,536 
預付金 和 存款  6   972,469    1,342,215 
 流動資產總額      7,334,586    6,681,975 
              
設備  8   514,940    680,801 
無形資產      47,962    56,426 
投資  7   14,286    189,403 
應收款項  5   156,200    - 
租用權資產  9   460,745    721,687 
總資產      $8,528,719   $8,330,292 
              
負債 及股東權益             
$             
交易 應付帳款及應計負債  17  $2,213,443   $2,638,981 
客戶存款      95,352    104,715 
遞延 收入  11   14,428    12,112 
應付 銀行貸款  12   -    85,058 
衍生 負債  13   1,252,005    4,196,125 
租賃負債  10   210,012    362,001 
 當期負債總計       3,785,240    7,398,992 
              
非流動 負債             
遞延 收入  11   68,672    95,562 
租賃 負債  10   313,848    428,022 
總計 負債      4,167,760    7,922,576 
              
股東權益             
分享 資本  13   106,191,431    97,070,976 
儲備 – 以股份為基礎的支付  13   7,273,102    6,870,139 
認股權證  13   3,776,428    - 
累積虧損      (112,743,907)   (103,588,356)
累積其他綜合收益      (136,095)   54,957 
總計 股東權益      4,360,959    407,716 
負債及股東權益總計     $8,528,719   $8,330,292 

 

自然 及營運之持續(附註1)

 

經董事會於2024年11月14日批准並授權發行。

 

“斯科特 拉爾森”   “卡梅隆 欺騙”
董事   董事

 

所附的附註是這些簡明綜合中期基本報表不可或缺的一部分。

 

2
 

 

Draganfly 公司。

簡明 綜合中期全面損失報表 - 未經審核

以加幣表示

 

                    
      截至   截至九個月結束時 
      2024年9月30日   2023年9月30日   2024年9月30日   2023年9月30日 
                    
商品銷售  14  $1,328,675   $1,653,111   $3,953,974   $4,615,285 
服務提供  14   556,647    484,906    993,920    1,023,257 
總收入      1,885,322    2,138,017    4,947,894    5,638,542 
                        
銷售成本  5   (1,444,542)   (1,243,334)   (3,765,429)   (3,833,308)
                        
毛利潤      440,780    894,683    1,182,465    1,805,234 
                        
營業費用                       
攤銷     $2,821   $8,990   $8,464   $26,969 
折舊  8, 9   139,358    137,880    424,039    362,123 
董事酬勞  17   131,469    148,914    375,369    452,154 
保險      234,279    423,036    954,259    1,429,466 
辦公室和雜項  15   508,554    1,605,520    1,375,985    5,843,576 
專業費用      774,069    1,108,983    2,242,807    3,530,057 
研發      347,373    59,792    659,832    1,408,476 
以股份為基礎的支付  13,17   400,575    788,824    904,629    1,808,302 
旅行      57,436    222,105    174,367    515,691 
工資和薪金  17   1,529,144    1,852,095    4,932,183    5,821,493 
 營業費用總額      (4,125,078)   (6,356,139)   (12,051,934)   (21,198,307)
其他收入(支出)                       
衍生負債公允價值變化  13   3,575,559    -    2,788,734    57,314 
財務及其他收益      38,632    30,714    85,436    77,466 
匯率期貨損益      (48,216)   86,718    26,344    (106,357)
處置資產帶來的收益(損失)      7,846    600    32,148    16,295 
應收票據回收(減損)收益(損失)      7,564    (104,780)   18,425    (104,780)
政府收入      -    1,319    -    3,891 
其他收入(費用)  16   (97,281)   -    (1,237,169)   25,769 
 總計 其他收入(費用)     $3,484,104   $14,571   $1,713,918   $(30,402)
                        
凈利潤(損失)     $(200,194)  $(5,446,885)  $(9,155,551)  $(19,423,475)
其他綜合損益                       
可能重分類至損益的項目                       
外匯期貨翻譯      1,086    (449)   (15,935)   (108,626)
不會重新分類為損益的項目                       
公允價值變動的權益投資(FVOCI)變動  7   (165,441)   (82,914)   (175,117)   14,046 
綜合收益(損失)      (364,549)   (5,530,248)   (9,346,603)   (19,518,055)
                        
每股凈收益(損失)- 基本與稀釋     $(0.06)  $(3.13)  $(3.28)  $(11.99)
普通股權加權平均已發行股份數-基本與稀釋後      3,351,778    1,738,779    2,794,072    1,619,343 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited

Expressed in Canadian Dollars

 

                                         
                             Accumulated Other Comprehensive Income (Loss)      
    Number of Shares    Share Capital    Reserve – Share-Based Payments    Warrants    Accumulated Deficit    Change in Fair
Value of
Investments at
FVTOCI
    Exchange
Differences on
Translation of
Foreign
Operations
    Total
Shareholders’
Equity (Deficit)
 
Balance at December 31, 2022   1,371,204   $83,600,089   $7,264,340   $-   $(79,976,546)  $          (431,123)  $            584,121   $11,040,881 
Shares issued for financing – ATM(1)   26,030    1,748,946    -    -    -    -    -    1,748,946 
Share issue costs   -    (222,136)   -    -    -    -    -    (222,136)
Shares issued for financing   320,000    10,856,166    -    -    -    -    -    10,856,166 
Share issue costs   -    (1,786,980)   -    -    -    -    -    (1,786,980)
Shares issued for the exercise of RSUs   37,159    1,323,551    (1,323,551)   -    -    -    -    - 
Share-based payments   -    -    1,808,302    -    -    -    -    1,808,302 
Net loss   -    -    -    -    (19,423,475)   -    -    (19,423,475)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    14,046    -    14,046 
Translation of foreign operations   -    -    -    -    -    -    (108,626)   (108,626)
Balance at September 30, 2023   1,754,393   $95,519,636   $7,749,091   $-   $(99,400,021)  $(417,077)  $475,495   $3,927,124 
Shares issued for financing   192,000    520,064    -    -    -    -    -    520,064 
Share issue costs   -    (285,906)   224,868    -    -    -    -    (61,038)
Shares issued for the exercise of RSUs   23,173    1,317,182    (1,317,182)   -    -    -    -    - 
Share-based payments   -    -    213,362    -    -    -    -    213,362 
Net loss   -    -    -    -    (4,188,335)   -    -    (4,188,335)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (17,226)   -    (17,226)
Translation of foreign operations   -    -    -    -    -    -    13,765    13,765 
Balance at December 31, 2023   1,969,566   $97,070,976   $6,870,139   $-   $(103,588,356)  $(434,303)  $489,260   $407,716 
Shares issued for financing   1,077,208    5,111,911    -    -    -    -    -    5,111,911 
Share issue costs   -    (877,474)   327,696    -    -    -    -    (549,778)
Shares issued for the exercise of warrants   791,668    4,056,657    -    -    -    -    -    4,056,657 
Shares issued for the exercise of RSUs   22,766    829,361    (829,361)   -    -    -    -    - 
Shares returned to treasury   (36,000)   -    -    -    -    -    -    - 
Warrants – equity treatment   -    -    -    3,776,428    -    -    -    3,776,428 
Share-based payments   -    -    904,628    -    -    -    -    904,628 
Net loss   -    -    -    -    (9,155,551)   -    -    (9,155,551)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (175,117)   -    (175,117)
Translation of foreign operations   -    -    -    -    -    -    (15,935)   (15,935)
Balance at September 30, 2024   3,825,208   $106,191,431   $7,273,102   $3,776,428   $(112,743,907)  $(609,420)  $473,325   $4,360,959 

 

(1)At the market

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Cash Flows - Unaudited

Expressed in Canadian Dollars

 

         
   For the nine months ended September 30, 
   2024   2023 
         
OPERATING ACTIVITIES          
Net loss  $(9,155,551)  $(19,423,475)
Adjustments for:          
Amortization   8,464    26,969 
Depreciation   424,039    362,123 
Impairment of accounts receivable   -    198,513 
Change in fair value of derivative liability   (2,788,734)   (57,314)
Impairment of inventory   148,760    208,247 
Impairment (Gain) on recovery of notes receivable   (18,425)   104,780 
Finance and other costs   1,204,434    3,893 
Gain on disposal of assets   (22,553)   (16,295)
Share-based payments   904,629    1,808,302 
Adjustments for profit loss   (9,294,937)   (16,784,257)
Net changes in non-cash working capital items:          
Receivables   (360,757)   743,149 
Inventory   (62,595)   (993,769)
Prepaids   369,747    482,491 
Trade payables and accrued liabilities   (220,627)   1,236,740 
Customer deposits   (9,363)   (145,804)
Deferred income   (24,574)   74,110 
Cash used in operating activities   (9,603,106)   (15,387,340)
           
INVESTING ACTIVITIES          
Purchase of equipment   (73,027)   (410,387)
Disposal of equipment   103,923    46,976 
Repayment of notes receivable   18,425    63,833 
Cash provided by (used in) investing activities   49,321    (299,578)
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   12,479,693    12,605,112 
Share issue costs   (2,036,067)   (2,009,116)
Proceeds from issuance of common shares for warrants exercised   373,244    - 
Repayment of loans   (85,058)   (5,060)
Repayment of lease liabilities   (258,127)   (233,089)
Cash provided by (used in) financing activities   10,473,685    10,357,847 
           
Effects of exchange rate changes on cash   (15,935)   (108,626)
Change in cash   919,900    (5,329,071)
Cash and cash equivalents, beginning of period   3,093,612    7,894,781 
Cash and cash equivalents, end of period  $3,997,577   $2,457,084 
           
SUPPLEMENTARY CASH FLOW DISCLOSURE          
Interest paid  $15,428   $80,258 
Share issue costs in accounts payable   71,912    52,216 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

1.NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $112,743,907. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These condensed consolidated interim financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

2.BASIS OF PREPARATION

 

Statement of Compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2023.

 

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on November 14, 2024.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary   Place of Incorporation   Ownership Interest
Draganfly Innovations Inc. (“DII”)   Canada   100%
Draganfly Innovations USA, Inc. (“DI USA”)   US   100%
Dronelogics Systems Inc. (“Dronelogics”)   Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

6
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

3.MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS

 

Adoption of new policy

 

The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units for equity treatment warrants, whereby the carrying amount of the warrants is determined based on any difference between gross proceeds and the estimated fair market value of the common shares. If the proceeds from the offering are less than or equal to the estimated fair market value of common shares issued, no value is assigned to the warrants. Warrants that are issued as payment to a finder or other transaction costs are accounted for as share-based payments.

 

Material Accounting Policy Information

 

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as in outlined in the Company’s consolidated financial statements for the year ended December 31, 2023. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual financial statements for the year ended December 31, 2023.

 

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2023.

 

4.RECEIVABLES

 

As at  September 30, 2024   December 31, 2023 
Trade accounts receivable  $981,369   $610,443 
Sales tax receivable   29,000    39,169 
 Trade and other receivables  $1,010,369   $649,612 
Current portion  $854,169   $649,612 
Long term portion   156,200    - 
 Trade and other receivables  $1,010,369   $649,612 

 

During the nine months ended September 30, 2024, the Company recorded a provision for doubtful accounts of $40,409 (2023 – $198,513).

 

The long-term receivable represents a refundable deposit that the Company has asked to have returned. The agreement allows for a two-year repayment term once the request has been made.

 

5.INVENTORY

 

As at  September 30, 2024   December 31, 2023 
Finished goods  $1,473,771   $904,858 
Parts   36,600    691,678 
 Inventories  $1,510,371   $1,596,536 

 

During the three and nine months ended September 30, 2024, $1,152,068 (2023 - $927,912) and $3,296,218 (2023 – $3,199,976) of inventory was recognized in cost of sales respectively including an allowance to value its inventory for obsolete and slow-moving inventory of $176,422 (2023 - $77,047) and $459,591 (2023 - $199,647) respectively.

 

7
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

5. INVENTORY (CONT’D)

 

Cost of sales consist of the following:

 

For the nine months ended  September 30, 2024   September 30, 2023 
Inventory  $3,296,218   $3,199,976 
Consulting and services   418,035    468,959 
Other   51,176    164,373 
 Cost of sales  $3,765,429   $3,833,308 

 

6.PREPAIDS AND DEPOSITS

 

As at  September 30, 2024   December 31, 2023 
Insurance  $525,510   $838,445 
Prepaid other   160,032    142,124 
Deposits   286,927    361,646 
 Prepaid expenses and deposits  $972,469   $1,342,215 

 

7.INVESTMENTS

 

Balance at December 31, 2023  $189,403 
Change in fair value   (175,117)
Balance at September 30, 2024  $14,286 

 

Fair value of investments is comprised of:

 

Public company shares   $14,286 
Private company shares    - 
Balance at September 30, 2024   $14,286 

 

The Company holds 1,428,571 shares of a publicly listed company with an initial cost of $500,000.

 

The Company holds 50,000 common shares of a private company with an initial value of USD$100,000. The Company considers if observable market data exists on a quarterly basis to value the investment. During the quarter ended September 30, 2024 the Company recognized and impairment of $134,910 (USD $100,000) based on publicly available information.

 

8
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

8.EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Vehicles   Total 
Cost                         
Balance at December 31, 2022  $95,662   $834,453   $-   $36,033   $966,148 
Additions   58,611    320,943    86,530    24,310    490,394 
Disposals   (21,000)   (115,204)   -    -    (136,204)
Balance at December 31, 2023   133,273    1,040,192    86,530    60,343    1,320,338 
Additions   6,876    63,792    2,359    -    73,027 
Disposals   (9,821)   (172,611)   -    -    (182,432)
Balance at September 30, 2024  $130,328   $931,373   $88,889   $60,343   $1,210,933 
                          
Accumulated depreciation                         
Balance at December 31, 2022  $41,998   $502,790   $-   $16,669   $561,457 
Charge for the year   22,762    112,361    6,790    12,497    154,410 
Disposals   (6,582)   (69,748)   -    -    (76,330)
Balance at December 31, 2023   58,178    545,403    6,790    29,166    639,537 
Charge for the period   29,643    107,486    13,374    7,015    157,518 
Disposals   (3,383)   (97,679)   -    -    (101,062)
Balance at September 30, 2024  $84,438   $555,210   $20,164   $36,181   $695,993 
                          
Net book value:                         
December 31, 2023  $75,095   $494,789   $79,740   $31,177   $680,801 
September 30, 2024  $45,890   $376,163   $68,725   $24,162   $514,940 

 

9.RIGHT OF USE ASSETS

 

   Vehicles   Buildings   Land   Total 
                 
Balance at December 31, 2022  $2,385   $342,361   $-   $344,746 
Additions   -    322,354    418,001    740,355 
Depreciation   (2,385)   (149,644)   (211,057)   (363,086)
Foreign exchange translation   -    -    (328)   (328)
Balance at December 31, 2023  $-   $515,071   $206,616   $721,687 
Depreciation  $-   $(107,046)  $(159,476)  $(266,522)
Foreign exchange translation   -    -    5,580    5,580 
Balance at September 30, 2024  $-   $408,025   $52,720   $460,745 

 

The Company has four leases with expiration dates of December 31, 2024, May 31, 2026, January 31, 2027, and September 30, 2028.

 

9
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

10.LEASE LIABILITIES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 13.25%. Extension options are included in a majority of the leases with options that are only exercisable by the Company and not the other party.

 

As at  Total 
Balance at December 31, 2022  $378,643 
Interest expense   96,423 
Additions   734,903 
Lease payments   (423,410)
Foreign exchange translation   3,464 
Balance at December 31, 2023   790,023 
Interest expense   53,017 
Lease payments   (311,145)
Foreign exchange translation   (8,035)
Balance at September 30, 2024  $523,860 

 

Which consists of:        
   September 30, 2024   December 31, 2023 
Current lease liability  $210,012   $362,001 
Non-current lease liability   313,848    428,022 
Ending balance  $523,860   $790,023 

 

Maturity analysis   Total 
Less than one year   $251,129 
One to three years    282,419 
Four to five years    71,836 
Total undiscounted lease liabilities    605,384 
Amount representing interest    (81,524)
Lease liability   $523,860 

 

11.DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

As at  September 30, 2024   December 31, 2023 
Deferred income from customers  $-   $12,112 
Deferred income from government   83,100    95,562 
Deferred income gross  $83,100   $107,674 
Current portion  $14,428   $12,112 
Long-term portion   68,672    95,562 
Deferred income net  $83,100   $107,674 

 

Deferred revenue of $14,428 as of September 30, 2024 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 4 years.

 

10
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

12.LOANS PAYABLE

 

As at  September 30, 2024   December 31, 2023 
Opening balance  $85,058   $86,571 
Repayment of loans payable   (85,058)   (6,747)
Accretion expense   -    5,234 
Ending balance  $-   $85,058 

 

   Start Date  Maturity Date  Rate   Carrying Value
September 30, 2024
  

Carrying Value

December 31, 2023

 
CEBA  2020-05-19  2024-03-28   0%  $-   $40,000 
CEBA  2021-04-23  2024-03-28   0%   -    40,000 
Vehicle loan  2019-08-30  2024-09-11   6.99%   -    5,058 
Total             $-   $85,058 

 

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle. The CEBA loans were repaid March 25, 2024. The vehicle loan was fully paid in September 2024.

 

13.SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the nine months ended September 30, 2024,

 

The Company issued 22,766 common shares for the vesting of restricted share units.
   
 The Company issued 791,668 common shares for the exercise of warrants
   
 On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025.
   
 36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. All value that had been recorded related to these shares had been previously written off
   
 On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615 for net proceeds of $4,102,553. Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.
   
On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676 for net proceeds of $2,376,374. The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.

  

11
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

13. SHARE CAPITAL (CONT’D)

 

During the year ended December 31, 2023,

 

The Company issued 60,332 common shares for the vesting of restricted share units.
   
The Company issued 320,000 common shares in a financing for $10,856,166 with share issuance costs of $1,953,032 for net proceeds of $8,903,134.
   
The Company issued 26,030 common shares in an ATM (“At – the - market”) financing for $1,748,946 with share issuance costs of $222,136 for net proceeds of $1,526,810.
   
The Company issued 192,000 common shares in a financing for proceeds of $4,858,995 with share issuance costs of $889,623 for net proceeds of $3,969,372. Of the total share issuance costs $793,979 were expensed in other income (expense). Value of the issuance was allocated $520,064 to the shares and $4,338,931 to derivative liability.

 

Share consolidation

 

On September 5, 2024 the Company effected a 25:1 share consolidation. All share, warrant, option and RSU numbers in these statements are shown post consolidation, including exercise prices, unless otherwise noted.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

As at September 30, 2024, the Company had the following options outstanding and exercisable:

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $62.50    5.07    11,130    11,134 
November 19, 2019  November 19, 2029  $62.50    5.13    2,000    2,000 
April 30, 2020  April 30, 2030  $62.50    5.57    320    320 
April 30, 2020  April 30, 2030  $96.25    5.57    4,400    4,400 
July 3, 2020  July 3, 2025  $80.00    0.75    4,000    4,000 
November 24, 2020  November 24, 2030  $62.50    6.14    1,280    1,280 
February 2, 2021  February 2, 2031  $330.00    6.33    1,200    1,200 
March 8, 2021  March 8, 2026  $347.50    1.43    400    400 
April 27, 2021  April 27, 2031  $253.75    6.56    4,840    4,774 
September 9, 2021  September 9, 2026  $121.00    1.94    1,034    1,034 
November 9, 2023  November 9, 2033  $15.65    9.09    1,200    400 
                 31,804    30,942 

 

12
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

13. SHARE CAPITAL (CONT’D)

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2022   35,154   $115.00 
Forfeited   (400)   94.25 
Issued   1,200    15.65 
Outstanding, December 31, 2023   35,954   $112.00 
Forfeited   (4,150)   111.61 
Outstanding, September 30, 2024   31,804   $111.99 

 

No options were granted by the Company during the nine months ended September 30, 2024.

 

During the three and nine months ended September 30, 2024, the Company recorded $5,600 (2023 – $27,425) and $58,979 (2023 - $130,437) respectively in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model.

 

Restricted Share Units

 

During the three and nine months ended September 30, 2024, the Company recorded share-based payment expense of $394,975 (2023 - $451,490) and $845,650 (2023 - $889,041) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at September 30, 2024, the Company had the following RSUs outstanding:

SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS

 

   Number of RSUs 
Outstanding, December 31, 2022   47,982 
Vested   (60,331)
Issued   67,413 
Forfeited   (10,519)
Outstanding, December 31, 2023   44,545 
Vested   (22,750)
Issued   185,218 
Forfeited   (10,487)
Outstanding, September 30, 2024   196,526 

 

13
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

13. SHARE CAPITAL (CONT’D)

 

Warrants

 

During the nine months ended September 30, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company’s functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD so are also accounted for as a liability. In addition, the Company also issued pre-funded warrants with an exercise price in Canadian dollars (“Pre-funded Warrants”). These are also treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also accounted for as a liability as these also contain clauses that do not meet the fixed for fixed test.

 

On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to CAD $0.2250 or CAD $5.625 on a post share consolidation basis. The exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of CAD $5.6925. For the October 2023 issuance and the April 2024 issuance, the warrant agreements were further amended as of August 7, 2024 to remove the cashless exercise feature and any anti-dilution clauses that would lead to variability in settlement so they now meet the requirement for equity treatment of the warrants. The warrants were fair values on August 7, 2024 and transferred to equity.

 

The warrants issued as part of the August 2024 issuance were issued with a CAD exercise price, no cashless exercise feature and no anti-dilution clauses that would lead to variability in settlement.

 

To reach a fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

 

Summary of issue date fair value inputs

 SCHEDULE OF ISSUE DATE FAIR VALUE INPUTS OF WARRANTS

 

   February Issuance   April Issuance   August Issuance 
   Warrants   Broker   Warrants   Broker   Broker 
Volatility   119.23%   107.8%   119.80%   108.67%   118.87%
Risk free rate   4.33%   4.48%   4.65%   4.62%   3.74%
Expected life   5 years    3 years    5 years    3 years    3 years 
Expected dividend yield   0%   0%   0%   0%   0%

 

14
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

13. SHARE CAPITAL (CONT’D)

 

Warrant Derivative Liability

 SCHEDULE OF WARRANT DERIVATIVE LIABILITY

 

Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110 
Balance at December 31, 2023  $4,196,125 
Warrants issued   7,282,325 
Warrants exercised   (3,661,282)
Change in fair value of warrants outstanding   (2,788,734)
Reclassify amended warrants to equity   (3,776,429)
Balance at September 30, 2024  $1,252,005 

 

Warrants – Equity Treatment

SCHEDULE OF WARRANTS EQUITY TREATMENT

 

Balance at December 31, 2023  $- 
Reclassification of amended warrants   3,776,428 
Balance at September 30, 2024  $3,776,428 

 

Details of liability warrants and their fair values are as follows:

 

SCHEDULE OF WARRANT AND FAIR VALUE OUTSTANDING

Issue Date  Exercise Price   Number of Warrants Outstanding at
September 30, 2024
   Fair Value at
September 30, 2024
   Number of Warrants Outstanding at
December 31, 2023
   Fair Value at
December 31, 2023
 
Derivative Liability                         
February 26, 2024 (1)  US$4.4025    474,332    1,252,005    -    - 
October 30, 2023 (2)  CAD$5.6925    -    -    256,000    3,180,543 
October 30, 2023 (3)  US$0.003    -    -    64,000    1,015,582 
         474,332    $1,252,005    320,000   $4,196,125 

 

1)The warrants expire February 26, 2029.
2)The warrant terms were amended and warrants were reclassified to equity August 7,2024
3)The warrants have no expiry date. They were exercised January 5, 2024.

 

Details of the warrants treated as equity and their fair values are as follows:

 SCHEDULE OF DETAILS OF THE WARRANTS TREATED AS EQUITY

 

Warrants – Equity Treatment

 

   Exercise Price   Number of Warrants Outstanding at September 30, 2024   Fair value at September 30, 2024   Number of Warrants Outstanding at December 31, 2023   Fair Value at December 31, 2023 
October 30, 2023 (1)  CAD$5.6925    256,000    $1,187,147    -   $- 
April 29, 2024 (2)  CAD$5.625    540,541    2,589,281    -    - 
August 21, 2024 (3)  CAD$5.12    666,667    -    -    - 
         1,463,208    $3,776,428    -   $-  

 

1)The warrants expire October 30, 2028. These were moved from derivative liability August 7, 2024.
2)The warrants expire April 29, 2029. These were moved from derivative liability August 7, 2024.
3)The warrants expire August 21, 2029.

 

15
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

13. SHARE CAPITAL (CONT’D)

 

The fair values of the derivative warrants and were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS 

 

   September 30, 2024   December 31, 2023 
Risk free interest rate   3.58%   3.84%
Expected volatility   120.48%   113.78%
Expected life   4.66 years    4.8 years 
Expected dividend yield   0%   0%

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2022   316,672   $147.53 
Issued   332,800    20.66 
Expired   (306,480)   153.52 
Outstanding, December 31, 2023   342,992   $15.75 
Issued   2,496,370    4.38 
Exercised   (791,668)   0.4661 
Expired   (10,192)   125.00 
Outstanding September 30, 2024   2,037,502   $6.14 

 

As at September 30, 2024, the Company had the following warrants outstanding:

SCHEDULE OF WARRANTS OUTSTANDING

 

Date issued  Expiry date   Exercise price   Number of warrants outstanding 
October 30, 2023   October 30, 2026   CAD$23.20    12,800 
October 30, 2023   October 30, 2028   CAD$ 5.6925    256,000 
February 26, 2024   February 26, 2027   US$8.44    26,800 
February 26, 2024   February 26, 2029   US$4.4025    474,332 
April 29, 2024   April 29, 2029   CAD$5.625    540,541 
April 29, 2024   April 29, 2024   CAD$11.06    27,028 
August 21, 2024   August 21, 2027   CAD$5.12    33,334 
August 21, 2024   August 21, 2029   CAD$5.12    666,667 
              2,037,502 

 

The weighted average remaining contractual life of warrants outstanding as of September 30, 2024, was 4.51 years (December 31, 2023 – 4.63 years).

 

16
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

14.SEGMENTED INFORMATION

 

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

 

September 30, 2024  Drones   Vital   Corporate   Total 
Sales of goods  $3,953,974   $-   $-   $3,953,974 
Provision of services   973,202    20,718    -    993,920 
Total revenue   4,927,176    20,718    -    4,947,894 
Segment loss (income)   4,509,638    (20,718)   1,165,111    5,654,031 
Finance and other costs   85,436    -    -    85,436 
Depreciation   412,544    -    11,495    424,039 
Amortization   8,464    -    -    8,464 
Change in fair value of derivative liability   -    -    2,788,734    2,788,734 
Loss on write-off of notes receivable   -    -    18,425    18,425 
Loss on write down of inventory   176,422    -    -    176,422 
Net loss for the period  $5,192,504   $(20,718)  $3,983,765   $9,155,551 

 

September 30, 2023  Drones   Vital   Corporate   Total 
Sales of goods  $4,215,220   $400,065   $-   $4,615,285 
Provision of services   1,023,257    -    -    1,023,257 
Total revenue   5,238,477    400,065    -    5,638,542 
Segment loss   12,812,936    (140,366)   6,183,566    18,856,136 
Finance and other costs   (74,397)   -    (3,069)   (77,466)
Depreciation   354,139    -    7,984    362,123 
Amortization   26,969    -    -    26,969 
Change in fair value of derivative liability   -    -    (57,314)   (57,314)
Loss on write-off of notes receivable   -    -    104,780    104,780 
Loss on write down of inventory   208,247    -    -    208,247 
Net loss for the period  $13,327,894   $(140,366)  $6,235,947   $19,423,475 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

Geographic segmentation is as follows:

 

   As of
September 30, 2024
   As of
December 31, 2023
 
Non-current assets          
Canada  $1,141,414   $1,441,701 
United States   52,720    206,616 
Non-current assets  $1,194,134   $1,648,317 

 

                 
Geographic segmentation is as follows:  For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
Revenue                
Canada  $1,860,227   $1,736,850   $4,913,720   $5,227,983 
United States   25,095    401,167    34,174    410,559 
Revenue  $1,885,322   $2,138,017   $4,947,894   $5,638,542 

 

17
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

15.OFFICE AND MISCELLANEOUS

 

                 
   For the three months ended September 30,   For the nine months ended September 30, 
   2024   2023   2024   2023 
Advertising, Marketing, and Investor Relations  $204,942   $642,055   $547,700   $3,915,184 
Compliance fees   63,988    27,816    202,987    163,451 
Impairment of accounts receivable   -    -    -    198,513 
Contract Work   -    729,378    -    796,725 
Other   239,624    206,271    625,298    769,703 
Office and Miscellaneous Expenses  $508,554   $1,605,520   $1,375,985   $5,843,576 

 

16.OTHER EXPENSE

 

                 
   For the three months ended September 30,   For the nine months ended September 30, 
   2024   2023   2024   2023 
Share issue costs  $60,179   $-   $1,254,629   $- 
Write off of accounts (payable) receivable   40,409    -    (8,424)   - 
Gain on settlement of debt   -    -    -    (26,193)
Other   (3,307)   -    (9,036)   424 
Total Other expenses  $97,281   $-   $1,237,169   $(25,769)

 

17.RELATED PARTY TRANSACTIONS

 

Trade receivables/payables and accrued receivables/payables:

 

As at September 30, 2024, the Company had $10,874 (2023 - $40,095) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three and nine months ended September 30, 2024 and 2023 included:

 

                 
   For the three months ended September 30,   For the nine months ended September 30, 
   2024   2023   2024   2023 
Director fees  $131,469   $148,914   $375,368   $452,154 
Salaries   127,329    300,836    396,916    842,436 
Share-based payments   223,364    375,619    527,224    906,498 
Total  $482,162   $825,369   $1,299,508   $2,201,088 

 

During the three months ended September 30, 2024, the directors agreed to a 20% reduction in their fees for the quarter.

 

18
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

17. RELATED PARTY TRANSACTIONS (CONT’D)

 

Other related party transactions

 

                 
   For the three months ended September 30,   For the nine months ended September 30, 
   2024   2023   2024   2023 
Management fees paid to a company controlled by CEO and director  $109,437   $106,250   $325,125   $486,250 
Management fees paid to a company that the CEO holds an economic interest in   64,463    128,330    190,164    355,111 
Management fees paid to a company controlled by the former President and director   41,910    66,220    119,335    211,372 
Management fees paid to a company, total  $215,810   $300,800   $634,624   $1,052,733 

 

18.FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The majority of cash is deposited in bank accounts held with a major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies.

 

Receivables

 

Receivables primarily consist of trade receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

Trade receivables include balances of $268,630 that are past due with no corresponding allowance recorded. However, upon review of these balances, the expected credit loss rate for overdue balances is estimated to be nominal. A total of $11,216 of past due balances without allowances booked against them has been collected subsequent to period end.

 

19
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Nine Months Ended September 30, 2024

Expressed in Canadian Dollars (unaudited)

 

 

18. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial instruments are measured at fair value through profit and loss.

 

September 30, 2024  Level 1   Level 3   Total 
Cash  $3,997,577   $-   $3,997,577 
Equity securities in investee companies   14,286    -    14,286 
Derivative liability   -    1,252,005    1,252,005 
Total  $4,011,863   $1,252,005   $5,263,868 

 

December 31, 2023  Level 1   Level 3   Total 
Cash  $3,093,612    -   $3,093,612 
Equity securities in investee companies  $57,143   $132,260   $189,403 
Derivative liability   -    4,196,125    4,196,125 
Total  $3,150,755   $4,328,385   $7,479,140 

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

 

Type

 

 

Valuation technique

 

 

Key inputs

  Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

● Share price

● Risk free interest rate

● Dividend yield

Key unobservable inputs

● Expected volatility

 

The estimated fair value would increase (decrease) if:

● The price was higher (lower)

● The risk-free rate was higher (lower)

● The dividend yield was lower (higher)

● The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
       Nine months ended September 30, 2024   Year ended December 31, 2023 
Volatility   20%  $165,428   $291,149 

 

 

20